BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 15928285)

  • 21. Stepwise ablation approach versus pulmonary vein isolation in patients with paroxysmal atrial fibrillation: Randomized controlled trial.
    Faustino M; Pizzi C; Agricola T; Xhyheri B; Costa GM; Flacco ME; Capasso L; Cicolini G; Di Girolamo E; Leonzio L; Manzoli L
    Heart Rhythm; 2015 Sep; 12(9):1907-15. PubMed ID: 26051530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.
    Jaïs P; Cauchemez B; Macle L; Daoud E; Khairy P; Subbiah R; Hocini M; Extramiana F; Sacher F; Bordachar P; Klein G; Weerasooriya R; Clémenty J; Haïssaguerre M
    Circulation; 2008 Dec; 118(24):2498-505. PubMed ID: 19029470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy.
    Mesquita J; Cavaco D; Ferreira AM; Costa FM; Carmo P; Morgado F; Mendes M; Adragão P
    J Interv Card Electrophysiol; 2018 Jun; 52(1):39-45. PubMed ID: 29511973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ablation of persistent atrial fibrillation based on high density voltage mapping and complex fractionated atrial electrograms: A randomized controlled trial.
    Hwang J; Park HS; Han S; Lee CH; Kim IC; Cho YK; Yoon HJ; Chung JW; Kim H; Nam CW; Hur SH; Kim JY; Kim YS; Jang WS
    Medicine (Baltimore); 2021 Aug; 100(31):e26702. PubMed ID: 34397805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year clinical outcome after pulmonary vein isolation using the novel endoscopic ablation system in patients with paroxysmal atrial fibrillation.
    Metzner A; Schmidt B; Fuernkranz A; Wissner E; Tilz RR; Chun KR; Neven K; Konstantinidou M; Rillig A; Yoshiga Y; Mathew S; Koester I; Ouyang F; Kuck KH
    Heart Rhythm; 2011 Jul; 8(7):988-93. PubMed ID: 21354329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial.
    Romanov A; Pokushalov E; Artemenko S; Yakubov A; Stenin I; Kretov E; Krestianinov O; Grazhdankin I; Risteski D; Karaskov A; Steinberg JS
    J Interv Card Electrophysiol; 2015 Oct; 44(1):9-16. PubMed ID: 26133284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duty-cycled multi-electrode radiofrequency vs. conventional irrigated point-by-point radiofrequency ablation for recurrent atrial fibrillation: comparative 3-year data.
    De Greef Y; Buysschaert I; Schwagten B; Stockman D; Tavernier R; Duytschaever M
    Europace; 2014 Jun; 16(6):820-5. PubMed ID: 24443035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Direct Current Synchronized Cardioversion to Ibutilide-Guided Catheter Ablation for Long-Term Sinus Rhythm Maintenance After Isolated Pulmonary Vein Isolation of Persistent Atrial Fibrillation.
    Wang M; Zhao Q; Ding W; Cai S
    Am J Cardiol; 2017 Jun; 119(12):1997-2002. PubMed ID: 28501100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of antiarrhythmic drugs during ablation of persistent atrial fibrillation: observations from a large single-centre cohort.
    Lüker J; Sultan A; Sehner S; Hoffmann B; Servatius H; Willems S; Steven D
    Heart Vessels; 2016 Oct; 31(10):1669-75. PubMed ID: 26546306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy.
    Forleo GB; Mantica M; De Luca L; Leo R; Santini L; Panigada S; De Sanctis V; Pappalardo A; Laurenzi F; Avella A; Casella M; Dello Russo A; Romeo F; Pelargonio G; Tondo C
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):22-8. PubMed ID: 18775050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
    Raatikainen MJ; Hakalahti A; Uusimaa P; Nielsen JC; Johannessen A; Hindricks G; Walfridsson H; Pehrson S; Englund A; Hartikainen J; Kongstad O; Mortensen LS; Hansen PS;
    Int J Cardiol; 2015 Nov; 198():108-14. PubMed ID: 26163901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation.
    Pokushalov E; Romanov A; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):274-9. PubMed ID: 23210695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year clinical follow-up after pulmonary vein isolation using high-intensity focused ultrasound (HIFU) and an esophageal temperature-guided safety algorithm.
    Neven K; Metzner A; Schmidt B; Ouyang F; Kuck KH
    Heart Rhythm; 2012 Mar; 9(3):407-13. PubMed ID: 21978960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Prospective Randomized Trial.
    Theis C; Konrad T; Mollnau H; Sonnenschein S; Kämpfner D; Potstawa M; Ocete BQ; Bock K; Himmrich E; Münzel T; Rostock T
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1080-7. PubMed ID: 26297786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials.
    Turagam MK; Musikantow D; Whang W; Koruth JS; Miller MA; Langan MN; Sofi A; Choudry S; Dukkipati SR; Reddy VY
    JAMA Cardiol; 2021 Jun; 6(6):697-705. PubMed ID: 33909022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conventional radiofrequency catheter ablation compared to multi-electrode ablation for atrial fibrillation.
    Gal P; Aarntzen AE; Smit JJ; Adiyaman A; Misier AR; Delnoy PP; Elvan A
    Int J Cardiol; 2014 Oct; 176(3):891-5. PubMed ID: 25156854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticosteroid use during pulmonary vein isolation is associated with a higher prevalence of dormant pulmonary vein conduction.
    Andrade JG; Khairy P; Nattel S; Vanella A; Rivard L; Guerra PG; Dubuc M; Dyrda K; Thibault B; Talajic M; Mondesert B; Roy D; Macle L
    Heart Rhythm; 2013 Oct; 10(10):1569-75. PubMed ID: 23892341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension.
    Pokushalov E; Romanov A; Corbucci G; Artyomenko S; Baranova V; Turov A; Shirokova N; Karaskov A; Mittal S; Steinberg JS
    J Am Coll Cardiol; 2012 Sep; 60(13):1163-70. PubMed ID: 22958958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized study.
    Kircher S; Arya A; Altmann D; Rolf S; Bollmann A; Sommer P; Dagres N; Richter S; Breithardt OA; Dinov B; Husser D; Eitel C; Gaspar T; Piorkowski C; Hindricks G
    Europace; 2018 Nov; 20(11):1766-1775. PubMed ID: 29177475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ablation of Complex Fractionated Electrograms With or Without ADditional LINEar Lesions for Persistent Atrial Fibrillation (The ADLINE Trial).
    Ammar-Busch S; Bourier F; Reents T; Semmler V; Telishevska M; Kathan S; Hofmann M; Hessling G; Deisenhofer I
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):636-641. PubMed ID: 28316148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.